Rheumatoid arthritis II - therapeutic EULAR 2025: Do Not Miss – Rheumatoid arthritis II – Clinical (therapeutic) 1 Jun 20251 Jun 2025 Stephanie LingSteph is an NIHR Academic Clinical Lecturer, carrying out her research at the University of Manchester. Her research interests are focused on analysis of multi-omics methods to define predictors…
ACR Congress Do Not Miss… ACR Convergence 2024: Do Not Miss – Rheumatoid arthritis II – Clinical (therapeutic) 5 Nov 20246 Nov 2024 Piotr Kuszmiersz MD PhDPiotr has a PhD in Medical Sciences and is an internal medicine specialist, currently undertaking his rheumatology training at the Department of Rheumatology and Immunology, Jagiellonian University…
EULAR 2024 Highlights… EULAR 2024 Highlights – RA II – Clinical (therapeutic) 21 Jul 202421 Jul 2024 Author: Daliya Pencheva Aymon et al. (OP0092) assessed the incidence of infections in rheumatoid arthritis (RA) patients from 14 RA registries in the JAK-POT study. Data from 54,905 treatment initiations,…
Rheumatoid arthritis II - therapeutic EULAR 2024: Do Not Miss – Rheumatoid arthritis II – Clinical (therapeutic) 8 Jun 2024 Rositsa DachevaRositsa is a rheumatologist in Sofia, Bulgaria. Her interests include inflammatory arthritis, systemic lupus erythematosus, interstitial lung disease, systemic sclerosis and musculoskeletal ultrasound. Rositsa is a member of the…
ACR Congress Do Not Miss… ACR Convergence 2023 – Rheumatoid arthritis II – Clinical (therapeutic) 6 Nov 20236 Nov 2023 Stefan DinescuStefan is a rheumatology specialist and lecturer at the University of Medicine and Pharmacy Craiova (Romania). His main research interests include rheumatoid arthritis, spondyloarthritis and musculoskeletal ultrasound. Stefan is…
Rheumatoid arthritis II - therapeutic… [EULAR HL 2023] Rheumatoid Arthritis II- Clinical- Therapeutic 20 Jun 2023 Author: Lise Verhoef Cope et al. (OP0130) evaluated the feasibility, efficacy and acceptability of 52 weeks of abatacept compared to placebo in 213 individuals at risk of developing rheumatoid arthritis…
Rheumatoid arthritis II - therapeutic… Rheumatoid Arthritis II – Clinical (therapeutic) 29 May 202330 May 2023 Alessandro Giollo Alessandro Giollo currently serves as the lead of refractory arthritis, synovial biopsy and osteoporosis clinics at the Rheumatology Unit, University of Padova (Italy). His clinical work and research…
Rheumatoid arthritis II - therapeutic [ACR22] Rheumatoid Arthritis II – Clinical (Therapeutic) 29 Nov 20226 Dec 2022 Author: Daliya Pencheva Emery et al (L03) introduced the concept of stimulating human programmed cell death protein 1 (PD-1) as a new rheumatoid arthritis (RA) treatment. In a Phase 2a,…